NCT01706692 - Swiss Dermatology Network of Targeted Therapies (SDNTT) | Biotech Hunter

Enrollment

1,121

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 15, 2032

Study Completion Date

March 15, 2032

Conditions

Psoriasis

Interventions

BIOLOGICAL

Adalimumab

all dosages, frequencies and durations prescribed

BIOLOGICAL

Etanercept

all dosages, frequencies and durations prescribed

BIOLOGICAL

Infliximab

all dosages, frequencies and durations prescribed

BIOLOGICAL

Ustekinumab

all dosages, frequencies and durations prescribed

DRUG

Cyclosporine A

all dosages, frequencies and durations prescribed

DRUG

Fumaric acids

all dosages, frequencies and durations prescribed

DRUG

Methotrexate

all dosages, frequencies and durations prescribed

DRUG

Other anti-psoriatic systemic treatments

all dosages, frequencies and durations prescribed

Trial Locations (6)

CH-5001

RECRUITING

Aarau Cantonal Hospital, Aarau

CH-4031

RECRUITING

Basel University Hospital, Basel

CH-3001

RECRUITING

Inselspital - Bern University Hospital, Bern

CH-1011

RECRUITING

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne

CH-9007

RECRUITING

St. Gallen Cantonal Hospital, Sankt Gallen

CH-8091

RECRUITING

Zurich University Hospital, Zurich

All Listed Sponsors

lead

Swiss Dermatology Network for Targeted Therapies

OTHER